We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$39.2B
AUM Growth
+$2.5B
Cap. Flow
+$1.83B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.25%
Holding
3,494
New
280
Increased
1,537
Reduced
1,324
Closed
255

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Financials 8.97%
3 Healthcare 8.75%
4 Industrials 7.19%
5 Consumer Staples 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALSN icon
2851
Allison Transmission
ALSN
$10.3B
$205K ﹤0.01%
+6,092
New +$190K
BB icon
2852
BlackBerry
BB
$5.18B
$205K ﹤0.01%
29,811
+1,269
+4% +$9.43K
SFBS
2853
ServisFirst Bancshares
SFBS
$4.84B
$205K ﹤0.01%
+5,486
New +$174K
MGLN
2854
DELISTED
Magellan Health Services, Inc.
MGLN
$205K ﹤0.01%
+2,720
New +$174K
NBD
2855
DELISTED
Nuveen Build Am Bond Opp Fd
NBD
$205K ﹤0.01%
+9,804
New +$207K
TSI
2856
TCW Strategic Income Fund
TSI
$213M
$203K ﹤0.01%
38,069
+1,115
+3% +$5.88K
OHAI
2857
DELISTED
OHA Investment Corporation
OHAI
$203K ﹤0.01%
117,431
-11,374
-9% -$29.5K
CIT
2858
DELISTED
CIT Group Inc.
CIT
$203K ﹤0.01%
+4,761
New +$188K
RES icon
2859
RPC Inc
RES
$1.36B
$201K ﹤0.01%
+10,124
New +$190K
WNC icon
2860
Wabash National
WNC
$510M
$200K ﹤0.01%
12,671
+970
+8% +$13.2K
MCF
2861
DELISTED
Contango Oil & Gas Co.
MCF
$200K ﹤0.01%
21,448
-415
-2% -$3.94K
NE
2862
CALL
DELISTED
Noble Corporation
NE
$199K ﹤0.01%
+306,300
New +$1.8M
ACTG icon
2863
Acacia Research
ACTG
$465M
$198K ﹤0.01%
30,440
+4,340
+17% +$28.2K
EMES
2864
DELISTED
Emerge Energy Services LP
EMES
$198K ﹤0.01%
+16,100
New +$197K
VRN
2865
DELISTED
Veren
VRN
$196K ﹤0.01%
14,440
-6,714
-32% -$86K
GNC
2866
DELISTED
GNC Holdings, Inc.
GNC
$196K ﹤0.01%
+17,793
New +$278K
BBF
2867
DELISTED
BlackRock Municipal Income Investment Trust
BBF
$196K ﹤0.01%
13,998
+2,028
+17% +$28.9K
ASG
2868
Liberty All-Star Growth Fund
ASG
$343M
$194K ﹤0.01%
46,396
+425
+0.9% +$1.77K
PDT
2869
John Hancock Premium Dividend Fund
PDT
$628M
$194K ﹤0.01%
+12,368
New +$183K
TIER
2870
DELISTED
TIER REIT, Inc.
TIER
$194K ﹤0.01%
11,169
-659
-6% -$10.3K
VEDL
2871
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$194K ﹤0.01%
+15,659
New +$197K
ASX icon
2872
ASE Group
ASX
$82.7B
$193K ﹤0.01%
+38,331
New +$213K
TRIB
2873
Trinity Biotech
TRIB
$8.91M
$193K ﹤0.01%
186
-12
-6% -$12.4K
WMC
2874
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$193K ﹤0.01%
1,915
-7,465
-80% -$771K
IBM icon
2875
CALL
IBM
IBM
$223B
$192K ﹤0.01%
42,781
-1,360
-3% -$207K

Similar funds

Raymond James & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Raymond James & Associates held 3,494 positions worth $39.2B, up 6.8% from $36.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $1.83B of net new capital in Q4 2016, opening 280 new positions and adding to 1,537 existing holdings. Its largest new stake was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 9.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Reynolds American Inc, an estimated $76.5M trimmed.

  • Raymond James & Associates's largest Q4 2016 buy was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2016, an estimated $118M increase.
  • Raymond James & Associates's biggest Q4 2016 reduction was Reynolds American Inc, cutting an estimated $76.5M.
  • Raymond James & Associates fully exited Amsurg Corp in Q4 2016, selling an estimated $29.2M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $39.2B portfolio in Q4 2016.
  • Raymond James & Associates opened 280 new positions and closed 255 in Q4 2016.
  • Raymond James & Associates's portfolio value rose 6.8% quarter-over-quarter to $39.2B.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.